Søgeord (monkeypox) valgt.
37 emner vises.
1
Multiple introductions of monkeypox virus to Ireland during the international mpox outbreak, May 2022 to October 2023
Gabriel Gonzalez, Michael Carr, Tomás M Kelleher, Emer O’Byrne, Weronika Banka, Brian Keogan, Charlene Bennett, Geraldine Franzoni, Patrice Keane, Cliona Kenna, Luke W Meredith, Nicola Fletcher, Jose Maria Urtasun-Elizari, Jonathan Dean, Ciaran Browne, Fiona Lyons, Brendan Crowley, Derval Igoe, Eve Robinson, Greg Martin, Jeff Connell, Cillian F De Gascun and Daniel Hare
Eurosurveillance latest updates, 19.04.2024
Tilføjet 19.04.2024
BackgroundMpox, caused by monkeypox virus (MPXV), was considered a rare zoonotic disease before May 2022, when a global epidemic of cases in non-endemic countries led to the declaration of a Public Health Emergency of International Concern. Cases of mpox in Ireland, a country without previous mpox reports, could reflect extended local transmission or multiple epidemiological introductions. AimTo elucidate the origins and molecular characteristics of MPXV circulating in Ireland between May 2022 and October 2023. MethodsWhole genome sequencing of MPXV from 75% of all Irish mpox cases (182/242) was performed and compared to sequences retrieved from public databases (n = 3,362). Bayesian approaches were used to infer divergence time between sequences from different subclades and evaluate putative importation events from other countries. ResultsOf 242 detected mpox cases, 99% were males (median age: 35 years; range: 15–60). All 182 analysed genomes were assigned to Clade IIb and, presence of 12 distinguishable subclades suggests multiple introductions into Ireland. Estimation of time to divergence of subclades further supports the hypothesis for multiple importation events from numerous countries, indicative of extended and sustained international spread of mpox. Further analysis of sequences revealed that 92% of nucleotide mutations were from cytosine to thymine (or from guanine to adenine), leading to a high number of non-synonymous mutations across subclades; mutations associated with tecovirimat resistance were not observed. ConclusionWe provide insights into the international transmission dynamics supporting multiple introductions of MPXV into Ireland. Such information supported the implementation of evidence-informed public health control measures.
Læs mere
2
Outbreak of mpox caused by Monkeypox virus clade I in the Democratic Republic of the Congo
ECDC
ECDC Epidemiological Update, 5.04.2024
Tilføjet 5.04.2024
Since December 2023 there has been a large increase in the number of mpox cases reported in the Democratic Republic of the Congo (DRC).
Læs mere
3
Ongoing mpox outbreak in Kamituga, South Kivu province, associated with monkeypox virus of a novel Clade I sub-lineage, Democratic Republic of the Congo, 2024
Leandre Murhula Masirika, Jean Claude Udahemuka, Leonard Schuele, Pacifique Ndishimye, Saria Otani, Justin Bengehya Mbiribindi, Jean M. Marekani, Léandre Mutimbwa Mambo, Nadine Malyamungu Bubala, Marjan Boter, David F. Nieuwenhuijse, Trudie Lang, Ernest Balyahamwabo Kalalizi, Jean Pierre Musabyimana, Frank M. Aarestrup, Marion Koopmans, Bas B. Oude Munnink and Freddy Belesi Siangoli
Eurosurveillance latest updates, 15.03.2024
Tilføjet 15.03.2024
Since the beginning of 2023, the number of people with suspected monkeypox virus (MPXV) infection have sharply increased in the Democratic Republic of the Congo (DRC). We report near-to-complete MPXV genome sequences derived from six cases from the South Kivu province. Phylogenetic analyses reveal that the MPXV affecting the cases belongs to a novel Clade I sub-lineage. The outbreak strain genome lacks the target sequence of the probe and primers of a commonly used Clade I-specific real-time PCR.
Læs mere
4
Mpox outbreak in France: epidemiological characteristics and sexual behaviour of cases aged 15 years or older, 2022
Catarina Krug, Arnaud Tarantola, Emilie Chazelle, Erica Fougère, Annie Velter, Anne Guinard, Yvan Souares, Anna Mercier, Céline François, Katia Hamdad, Laetitia Tan-Lhernould, Anita Balestier, Hana Lahbib, Nicolas Etien, Pascale Bernillon, Virginie De Lauzun, Julien Durand, Myriam Fayad, Investigation Team, Henriette De Valk, François Beck, Didier Che, Bruno Coignard, Florence Lot and Alexandra Mailles
Eurosurveillance latest updates, 15.12.2023
Tilføjet 15.12.2023
BackgroundLocally-acquired mpox cases were rarely reported outside Africa until May 2022, when locally-acquired-mpox cases occurred in various European countries. AimWe describe the mpox epidemic in France, including demographic and behavioural changes among a subset of cases, during its course. MethodsData were retrieved from the enhanced national surveillance system until 30 September 2022. Laboratory-confirmed cases tested positive for monkeypox virus or orthopoxviruses by PCR; non-laboratory-confirmed cases had clinical symptoms and an epidemiological link to a laboratory-confirmed case. A subset of ≥ 15-year-old male cases, notified until 1 August, was interviewed for epidemiological, clinical and sexual behaviour information. Association of symptom-onset month with quantitative outcomes was evaluated by t- or Wilcoxon tests, and with binary outcomes, by Pearson’s chi-squared or Fisher exact tests. ResultsA total of 4,856 mpox cases were notified, mostly in Île-de-France region (62%; 3,025/4,855). Cases aged ≥ 15 years were predominantly male (97%; 4,668/4,812), with 37 years (range: 15–81) as mean age. Between May and July, among the subset interviewed, mpox cases increased in regions other than Île-de-France, and mean age rose from 35 (range: 21–64) to 38 years (range: 16–75; p = 0.007). Proportions of cases attending men-who-have-sex-with-men (MSM) meeting venues declined from 60% (55/91) to 46% (164/359; p = 0.012); median number of sexual partners decreased from four (interquartile range (IQR): 1–10) to two (IQR: 1–4; p
Læs mere
5
PRO/AH/EDR> Mpox update (16): cases, disparities, South Korea
ProMED, 23.04.2023
Tilføjet 23.04.2023
Mpox -- United StatesWhat is already known about this topic?Racial and ethnic disparities in monkeypox (mpox) incidence and vaccination have been described.What is added by this report?During 10 May 10-31 Dec 2022, mpox incidence among non-Hispanic Black or African American (Black) and Hispanic or Latino (Hispanic) males was higher than that among non-Hispanic White (White) males. Although overall ≥ 1-dose JYNNEOS vaccination rates were higher among Black and Hispanic males than White males, they were
Læs mere
6
PRO/AH/EDR> Mpox update (14): worldwide, USA, Congo DR (HU), vaccination
ProMED, 10.04.2023
Tilføjet 10.04.2023
Mpox -- United StatesSummary---------What is already known about this topic?- Jynneos vaccine is effective in preventing monkeypox (mpox) among persons at risk.What is added by this report?- During the current multinational outbreak, US 1- and 2-dose vaccination coverage reached an estimated 37% and 23%, respectively, among persons at risk, with wide variation among jurisdictions. The predominant administration route switched from subcutaneous to intradermal after the week of 20 Aug 2022 in accordance
Læs mere
7
PRO/AH/EDR> Mpox update (12) Japan, TikTok, Jamaica, vaccination
ProMED, 25.03.2023
Tilføjet 25.03.2023
Mpox -- JapanAbstract--------Background: Online information on mpox (monkeypox) is not well studied. We have analysed the video content, information quality, and audience engagement of mpox-related videos on TikTok.Methods: Using a hashtag-based searching strategy, we identified 2462 mpox-related videos on TikTok from 1 Jan to 11 Aug 2022; 85 were included after exclusion criteria screening. Videos were evaluated for content on features and treatment of mpox. Video and information quality was
Læs mere
8
Mpox outbreak in the Netherlands, 2022: public health response, characteristics of the first 1,000 cases and protection of the first-generation smallpox vaccine
Eurosurveillance latest updates, 23.03.2023
Tilføjet 24.03.2023
In early May 2022, a global outbreak of mpox started among persons without travel history to regions known to be enzootic for monkeypox virus (MPXV). On 8 August 2022, the Netherlands reported its 1,000th mpox case, representing a cumulative incidence of 55 per million population, one of the highest cumulative incidences worldwide. We describe characteristics of the first 1,000 mpox cases in the Netherlands, reported between 20 May and 8 August 2022, within the context of the public health response. These cases were predominantly men who have sex with men aged 31–45 years. The vast majority of infections were acquired through sexual contact with casual partners in private or recreational settings including LGBTQIA+ venues in the Netherlands. This indicates that, although some larger upsurges occurred from point-source and/or travel-related events, the outbreak was mainly characterised by sustained transmission within the Netherlands. In addition, we estimated the protective effect of first-generation smallpox vaccine against moderate/severe mpox and found a vaccine effectiveness of 58% (95% CI: 17–78%), suggesting moderate protection against moderate/severe mpox symptoms on top of any possible protection by this vaccine against MPXV infection and disease. Communication with and supporting the at-risk population in following mitigation measures remains essential.
Læs mere
9
PRO/AH/EDR> Mpox update (11): cases, incubation, reinfection, Mexico, Jynneos
ProMED, 18.03.2023
Tilføjet 18.03.2023
Monkeypox -- Andorra / 4 / 0Argentina / 1112 / 2Aruba / 3 / 0Australia / 144 / 0Austria / 327 / 0Bahamas / 2 / 0Bahrain / 1 / 0Barbados / 1 / 0Belgium / 793 / 2Benin / 3 / 0Bermuda / 1 / 0Bolivia / 265 / 0Bosnia and Herzegovina / 9 / 0Brazil / 10 878 / 15Bulgaria / 6 / 0Cameroon / 18 / 3Canada / 1460 / 0Central African Republic / 27 / 1Chile / 1435 / 2China / 1 / 0Colombia / 4085 / 0Costa Rica / 206 / 1Croatia / 33 / 0Cuba / 8 / 1Curacao / 3 / 0Cyprus / 5 /
Læs mere
10
PRO/AH/EDR> Mpox update (10): Taiwan, undetected case, death, treatment
ProMED, 12.03.2023
Tilføjet 12.03.2023
Monkeypox -- ChinaThe 1st batch of mpox vaccination would be offered to about 3000 people in targeted groups in the 6 special municipalities, the Centers for Disease Control (CDC) said yesterday [7 Mar 2023], as it reported Taipei's 1st local case of the disease formerly known as monkeypox.CDC Epidemic Intelligence Center Director Guo Hung-wei said the new mpox case is a man in his 30s who did not travel abroad recently. He developed a fever late last month [February 2023], as well as rashes and blisters on
Læs mere
11
PRO/AH/EDR> Mpox update (09): worldwide, USA, Taiwan, occupational transm, sampling, immunology
ProMED, 4.03.2023
Tilføjet 4.03.2023
Monkeypox -- Andorra / 4 / 0Argentina / 1099 / 2Aruba / 3 / 0Australia / 144 / 0Austria / 327 / 0Bahamas / 2 / 0Bahrain / 1 / 0Barbados / 1 / 0Belgium / 793 / 2Benin / 3 / 0Bermuda / 1 / 0Bolivia / 265 / 0Bosnia and Herzegovina / 9 / 0Brazil / 10 846 / 15Bulgaria / 6 / 0Cameroon / 18 / 3Canada / 1460 / 0Central African Republic / 27 / 1Chile / 1431 / 2China / 1 / 0Colombia / 4081 / 0Costa Rica / 188 / 0Croatia / 33 / 0Cuba / 8 / 1Curacao / 3 / 0Cyprus / 5 /
Læs mere
12
PRO/AH/EDR> Mpox update (08): worldwide, Belgium
ProMED, 25.02.2023
Tilføjet 25.02.2023
Monkeypox -- Andorra / 4 / 0Argentina / 1091 / 2Aruba / 3 / 0Australia / 144 / 0Austria / 327 / 0Bahamas / 2 / 0Bahrain / 1 / 0Barbados / 1 / 0Belgium / 793 / 1Benin / 3 / 0Bermuda / 1 / 0Bolivia / 264 / 0Bosnia and Herzegovina / 9 / 0Brazil / 10 808 / 15Bulgaria / 6 / 0Cameroon / 18 / 3Canada / 1460 / 0Central African Republic / 22 / 0Chile / 1426 / 2China / 1 / 0Colombia / 4080 / 0Costa Rica / 140 / 0Croatia / 33 / 0Cuba / 8 / 1Curacao / 3 / 0Cyprus / 5 /
Læs mere
13
PRO/AH/EDR> Mpox update (07): worldwide, USA, WHO, wastewater
ProMED, 17.02.2023
Tilføjet 17.02.2023
Monkeypox -- Andorra / 4 / 0Argentina / 1089 / 2Aruba / 3 / 0Australia / 144 / 0Austria / 327 / 0Bahamas / 2 / 0Bahrain / 1 / 0Barbados / 1 / 0Belgium / 793 / 1Benin / 3 / 0Bermuda / 1 / 0Bolivia / 264 / 0Bosnia and Herzegovina / 9 / 0Brazil / 10758 / 15Bulgaria / 6 / 0Cameroon / 18 / 3Canada / 1460 / 0Central African Republic / 22 / 0Chile / 1419 / 2China / 1 / 0Colombia / 4074 / 0Costa Rica / 140 / 0Croatia / 33 / 0Cuba / 8 / 1Curacao / 3 / 0Cyprus / 5 /
Læs mere
14
PRO/AH/EDR> Mpox update (06): worldwide, antivirals
ProMED, 10.02.2023
Tilføjet 10.02.2023
Monkeypox -- Andorra / 4 / 0Argentina / 1078 / 2Aruba / 3 / 0Australia / 144 / 0Austria / 327 / 0Bahamas / 2 / 0Bahrain / 1 / 0Barbados / 1 / 0Belgium / 793 / 1Benin / 3 / 0Bermuda / 1 / 0Bolivia / 264 / 0Bosnia and Herzegovina / 9 / 0Brazil / 10758 / 15Bulgaria / 6 / 0Cameroon / 18 / 3Canada / 1460 / 0Central African Republic / 22 / 0Chile / 1419 / 2China / 1 / 0Colombia / 4074 / 0Costa Rica / 140 / 0Croatia / 33 / 0Cuba / 8 / 1Curacao / 3 / 0Cyprus / 5 /
Læs mere
15
PRO/AH/EDR> Mpox update (05): worldwide, USA
ProMED, 2.02.2023
Tilføjet 2.02.2023
Monkeypox -- Andorra / 4 / 0Argentina / 1075 / 2Aruba / 3 / 0Australia / 144 / 0Austria / 327 / 0Bahamas / 2 / 0Bahrain / 1 / 0Barbados / 1 / 0Belgium / 793 / 1Benin / 3 / 0Bermuda / 1 / 0Bolivia / 263 / 0Bosnia and Herzegovina / 9 / 0Brazil / 10 745 / 15Bulgaria / 6 / 0Cameroon / 18 / 3Canada / 1460 / 0Central African Republic / 20 / 0Chile / 1416 / 2China / 1 / 0Colombia / 4072 / 0Costa Rica / 140 / 0Croatia / 33 / 0Cuba / 8 / 1Curacao / 3 / 0Cyprus / 5 /
Læs mere
16
PRO/AH/EDR> Mpox update (04): worldwide, USA, drug sensitivity, evolution, Viet Nam
ProMED, 27.01.2023
Tilføjet 27.01.2023
Monkeypox -- Andorra / 4 / 0Argentina / 1052 / 2Aruba / 3 / 0Australia / 144 / 0Austria / 327 / 0Bahamas / 2 / 0Bahrain / 1 / 0Barbados / 1 / 0Belgium / 790 / 1Benin / 3 / 0Bermuda / 1 / 0Bolivia / 263 / 0Bosnia and Herzegovina / 9 / 0Brazil / 10 690 / 15Bulgaria / 6 / 0Cameroon / 18 / 3Canada / 1460 / 0Central African Republic / 13 / 0Chile / 1406 / 2China / 1 / 0Colombia / 4062 / 0Costa Rica / 126 / 0Croatia / 33 / 0Cuba / 8 / 1Curacao / 3 / 0Cyprus / 5 /
Læs mere
17
PRO/AH/EDR> Mpox update (03): worldwide, USA, DR Congo
ProMED, 20.01.2023
Tilføjet 20.01.2023
Monkeypox -- Andorra / 4 / 0Argentina / 1037 / 2Aruba / 3 / 0Australia / 144 / 0Austria / 327 / 0Bahamas / 2 / 0Bahrain / 1 / 0Barbados / 1 / 0Belgium / 790 / 1Benin / 3 / 0Bermuda / 1 / 0Bolivia / 263 / 0Bosnia and Herzegovina / 9 / 0Brazil / 10 625 / 14Bulgaria / 6 / 0Cameroon / 18 / 3Canada / 1460 / 0Central African Republic / 13 / 0Chile / 1398 / 2China / 1 / 0Colombia / 4049 / 0Costa Rica / 77 / 0Croatia / 31 / 0Cuba / 8 / 1Curacao / 3 / 0Cyprus / 5 /
Læs mere
18
Epidemiological update: Monkeypox multi-country outbreak
ECDC Epidemiological Update, 14.01.2023
Tilføjet 14.01.2023
Since the start of the outbreak: A total of 1 158 cases have been confirmed in the EU/EEA and 1 882 cases have been confirmed worldwide (including the EU/EEA).
Læs mere
19
PRO/AH/EDR> Mpox update (02): worldwide, USA, antivirals
ProMED, 13.01.2023
Tilføjet 13.01.2023
Monkeypox -- Andorra / 4 / 0Argentina / 1025 / 2Aruba / 3 / 0Australia / 144 / 0Austria / 327 / 0Bahamas / 2 / 0Bahrain / 1 / 0Barbados / 1 / 0Belgium / 790 / 1Benin / 3 / 0Bermuda / 1 / 0Bolivia / 262 / 0Bosnia and Herzegovina / 9 / 0Brazil / 10593 / 14Bulgaria / 6 / 0Cameroon / 18 / 3Canada / 1460 / 0Central African Republic / 13 / 0Chile / 1391 / 2China / 1 / 0Colombia / 4049 / 0Costa Rica / 77 / 0Croatia / 31 / 0Cuba / 8 / 1Curacao / 3 / 0Cyprus / 5 /
Læs mere
20
PRO/AH/EDR> Mpox update (01): worldwide, USA, breakthrough cases, unvaccinated, women
ProMED, 6.01.2023
Tilføjet 6.01.2023
Monkeypox -- Andorra / 4 / 0Argentina / 1018 / 1Aruba / 3 / 0Australia / 144 / 0Austria / 327 / 0Bahamas / 2 / 0Bahrain / 1 / 0Barbados / 1 / 0Belgium / 790 / 1Benin / 3 / 0Bermuda / 1 / 0Bolivia / 261 / 0Bosnia and Herzegovina / 9 / 0Brazil / 10 544 / 14Bulgaria / 6 / 0Cameroon / 18 / 3Canada / 1460 / 0Central African Republic / 13 / 0Chile / 1387 / 2China / 1 / 0Colombia / 4035 / 0Costa Rica / 77 / 0Croatia / 31 / 0Cuba / 8 / 1Curacao / 3 / 0Cyprus / 5 /
Læs mere
21
PRO/AH/EDR> Mpox update (09): worldwide, USA, children, healthcare worker, STI
ProMED, 30.12.2022
Tilføjet 30.12.2022
Monkeypox -- Andorra / 4 / 0Argentina / 987 / 1Aruba / 3 / 0Australia / 144 / 0Austria / 327 / 0Bahamas / 2 / 0Bahrain / 1 / 0Barbados / 1 / 0Belgium / 790 / 1Benin / 3 / 0Bermuda / 1 / 0Bolivia / 261 / 0Bosnia and Herzegovina / 9 / 0Brazil / 10 398 / 14Bulgaria / 6 / 0Cameroon / 18 / 3Canada / 1459 / 0Central African Republic / 13 / 0Chile / 1367 / 3China / 1 / 0Colombia / 3971 / 0Costa Rica / 37 / 0Croatia / 29 / 0Cuba / 8 / 1Curacao / 3 / 0Cyprus / 5 /
Læs mere
22
Notes from the Field: Clinical and Epidemiologic Characteristics of Mpox Cases from the Initial Phase of the Outbreak - New York City, May 19-July 15, 2022
Morbidity and Mortality Weekly Report (MMWR), 30.12.2022
Tilføjet 30.12.2022
This report describes an analysis of mpox case data collected in New York City during the initial phase of the 2022 monkeypox outbreak.
Læs mere
23
PRO/AH/EDR> Mpox update (08): worldwide, USA, vaccine, viral load
ProMED, 23.12.2022
Tilføjet 23.12.2022
Monkeypox -- Andorra / 4 / 0Argentina / 987 / 1Aruba / 3 / 0Australia / 144 / 0Austria / 327 / 0Bahamas / 2 / 0Bahrain / 1 / 0Barbados / 1 / 0Belgium / 790 / 1Benin / 3 / 0Bermuda / 1 / 0Bolivia / 261 / 0Bosnia and Herzegovina / 9 / 0Brazil / 10 293 / 14Bulgaria / 6 / 0Cameroon / 18 / 3Canada / 1459 / 0Central African Republic / 13 / 0Chile / 1356 / 2China / 1 / 0Colombia / 3908 / 0Costa Rica / 37 / 0Croatia / 29 / 0Cuba / 8 / 1Curacao / 3 / 0Cyprus / 5 /
Læs mere
24
PRO/AH/EDR> Mpox update (07): worldwide, cases
ProMED, 21.12.2022
Tilføjet 21.12.2022
Monkeypox -- Andorra / 4Argentina / 987 (1 fatal)Aruba / 3Australia / 144Austria / 327Bahamas / 2Bahrain / 1Barbados / 1Belgium / 790 (1 fatal)Benin / 3Bermuda / 1Bolivia / 261Bosnia and Herzegovina / 9Brazil / 10 293 (14 Fatal)Bulgaria / 6Cameroon / 18 (2 fatal)Canada / 1459Central African Republic / 13Chile / 1356 (2 fatal)China / 1Colombia / 3908Costa Rica / 37Croatia / 29Cuba / 8 (1 fatal)Curacao / 3Cyprus / 5Czechia / 71Dem Republic Congo /
Læs mere
25
PRO/AH/EDR> Mpox update (06): worldwide
ProMED, 18.12.2022
Tilføjet 18.12.2022
Monkeypox -- Andorra / 4Argentina / 985 (1 fatal)Aruba / 3Australia / 144Austria / 327Bahamas / 2Bahrain / 1Barbados / 1Belgium / 790 (1 fatal)Benin / 3Bermuda / 1Bolivia / 261Bosnia and Herzegovina / 9Brazil / 10 264 (14 fatal)Bulgaria / 6Cameroon / 16 (2 fatal)Canada / 1459Central African Republic / 12Chile / 1356 (2 fatal)China / 1Colombia / 3908Costa Rica / 37Croatia / 29Cuba / 8 (1 fatal)Curacao / 3Cyprus / 5Czechia / 71 (1 fatal)Dem Republic Congo
Læs mere
26
Outcomes of post-exposure vaccination by modified vaccinia Ankara to prevent mpox (formerly monkeypox): a retrospective observational study in Lyon, France, June to August 2022
Eurosurveillance latest updates, 15.12.2022
Tilføjet 16.12.2022
Modified vaccinia virus Ankara vaccine (MVA-BN; Bavarian Nordic) is recommended to contacts of mpox cases up to 14 days post-exposure but the effectiveness of this strategy is unknown. Among 108 adults (≥ 18 years old) who received one dose of MVA-BN after exposure to mpox, 11 (10%) cases of breakthrough mpox were observed. Sexual exposure was associated with the risk of breakthrough mpox (p = 0.0179). Samples taken from vaccinated breakthrough mpox cases had similar rates of infectious virus isolation than unvaccinated mpox cases.
Læs mere
27
PRO/AH/EDR> Mpox update (05): worldwide, USA, vaccine, virulence, Egypt
ProMED, 16.12.2022
Tilføjet 16.12.2022
Monkeypox -- United StatesAndorra / 4 / 0Argentina / 972 / 1Aruba / 3 / 0Australia / 144 / 0Austria / 327 / 0Bahamas / 2 / 0Bahrain / 1 / 0Barbados / 1 / 0Belgium / 790 / 1Benin / 3 / 0Bermuda / 1 / 0Bolivia / 260 / 0Bosnia and Herzegovina / 9 / 0Brazil / 10 235 / 14Bulgaria / 6 / 0Cameroon / 16 / 2Canada / 1459 / 0Central African Republic / 12 / 0Chile / 1340 / 2China / 1 / 0Colombia / 3880 / 0Costa Rica / 37 / 0Croatia / 29 / 0Cuba / 8 / 1Curacao / 3 / 0Cyprus / 5 /
Læs mere
28
PRO/AH/EDR> Mpox update (04): worldwide cases
ProMED, 11.12.2022
Tilføjet 11.12.2022
Monkeypox -- Andorra / 4Argentina / 972 (1 fatal)Aruba / 3Australia / 143Austria / 327Bahamas / 2Bahrain / 1Barbados / 1Belgium / 790 (1 fatal)Benin / 3Bermuda / 1Bolivia / 260Bosnia and Herzegovina / 9Brazil / 10 231 (14 Fatal)Bulgaria / 6Cameroon / 16 (2 fatal)Canada / 1459Central African Republic / 12Chile / 1330 (2 fatal)China / 1Colombia / 3880Costa Rica / 37Croatia / 29Cuba / 8 (1 fatal)Curacao / 3Cyprus / 5Czechia / 71 (1 fatal)Dem Republic Congo
Læs mere
29
Communicable disease threats report, 4 – 10 December 2022, week 49
ECDC COVID-19 updates, 9.12.2022
Tilføjet 9.12.2022
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 4 – 10 December 2022 and includes updates on COVID-19, Ebola virus, respiratory syncytial virus, streptococcal infection, diphtheria, seasonal influenza, mpox (monkeypox), hepatitis, MERS-CoV, meningitis, and mass gathering monitoring at the FIFA World Cup 2022 Qatar.
Læs mere
30
Joint ECDC-WHO/Europe mpox (monkeypox) surveillance bulletin
ECDC Epidemiological Update, 8.12.2022
Tilføjet 8.12.2022
This report provides an overview of the total number of cases of mpox (monkeypox) reported to ECDC and the WHO Regional Office for Europe through IHR/EWRS mechanisms .
Læs mere
31
PRO/AH/EDR> Mpox update (02): worldwide cases
ProMED, 5.12.2022
Tilføjet 5.12.2022
Monkeypox -- Country / CasesAndorra / 4Argentina / 944 (1 fatal)Aruba / 3Australia / 143Austria / 327Bahamas / 2Bahrain / 1Barbados / 1Belgium / 789 (1 fatal)Benin / 3Bermuda / 1Bolivia / 258Bosnia and Herzegovina / 9Brazil / 10 044 (14 Fatal)Bulgaria / 6Cameroon / 16 (2 fatal)Canada / 1456Central African Republic / 12Chile / 1311 (3 fatal)China / 1Colombia / 3852Costa Rica / 24Croatia / 29Cuba / 8 (1 fatal)Curacao / 3Cyprus / 5Czechia / 71 (1
Læs mere
32
PRO/AH/EDR> Mpox update (01): new name, global, USA, saliva, new vaccines, viral shedding, corr
ProMED, 3.12.2022
Tilføjet 3.12.2022
Monkeypox -- Andorra / 4 / 0Argentina / 895 / 1Aruba / 3 / 0Australia / 143 / 0Austria / 326 / 0Bahamas / 2 / 0Bahrain / 1 / 0Barbados / 1 / 0Belgium / 789 / 1Benin / 3 / 0Bermuda / 1 / 0Bolivia / 253 / 0Bosnia and Herzegovina / 9 / 0Brazil / 9998 / 13Bulgaria / 6 / 0Cameroon / 16 / 2Canada / 1459 / 0Central African Republic / 12 / 0Chile / 1311 / 2China / 1 / 0Colombia / 3803 / 0Costa Rica / 24 / 0Croatia / 29 / 0Cuba / 8 / 1Curacao / 3 / 0Cyprus / 5 /
Læs mere
33
Communicable disease threats report, 27 November – 3 December 2022, week 48
ECDC COVID-19 updates, 2.12.2022
Tilføjet 2.12.2022
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 27 November – 3 December 2022 and includes updates on COVID-19, Ebola, diphtheria, respiratory syncytial virus, seasonal influenza, monkeypox, mass gathering monitoring at the FIFA World Cup 2022 Qatar, Chikungunya, dengue, Shigella sonnei, poliomyelitis, meningitis, cholera.
Læs mere
34
Mpox (formerly monkeypox) in women: epidemiological features and clinical characteristics of mpox cases in Spain, April to November 2022
Eurosurveillance latest updates, 1.12.2022
Tilføjet 2.12.2022
Over 79,000 confirmed cases of mpox were notified worldwide between May and November 2022, most of them in men who have sex with men. Cases in women, for whom mpox might pose different risks, are rare, and Spain has reported more than one third of those in Europe. Using surveillance data, our study found similar time trends, but differences in delay of diagnosis, sexual transmission and signs and symptoms between men and women.
Læs mere
35
Results of an interventional HIV testing programme in the context of a mpox (formerly monkeypox) vaccination campaign in Latium Region, Italy, August to October 2022
Eurosurveillance latest updates, 1.12.2022
Tilføjet 2.12.2022
HIV testing was offered to 2,185 people receiving mpox (formerly monkeypox) vaccination, who reported not being HIV positive. Among them 390 were current PrEP users, and 131 had taken PrEP in the past. Of 958 individuals consenting testing, six were newly diagnosed with HIV. Two patients had symptomatic primary HIV infection. None of the six patients had ever taken PrEP. Mpox vaccination represents an important opportunity for HIV testing and counselling about risk reduction and PrEP.
Læs mere
36
Severe mpox (formerly monkeypox) disease in five patients after recent vaccination with MVA-BN vaccine, Belgium, July to October 2022
Eurosurveillance latest updates, 1.12.2022
Tilføjet 2.12.2022
Vaccination is important in containing the 2022 mpox (formerly monkeypox) epidemic. We describe five Belgian patients with localised severe symptoms of proctitis and penile oedema, occurring between 4 and 35 days after post-exposure preventive vaccination or after one- or two-dose off-label pre-exposure preventive vaccination with MVA-BN vaccine. Genome sequencing did not reveal evidence for immune escape variants. Healthcare workers and those at risk should be aware of possible infections occurring shortly after vaccination and the need for other preventive measures.
Læs mere
37
New Model Aims to Aid Monkeypox Vaccine Distribution
Medscape Infectious Diseases, 2.12.2022
Tilføjet 2.12.2022
A new model has been developed to guide public health policy makers on the most efficient way to distribute a limited supply of monkeypox vaccines to those who need it the most. Medscape Medical News
Læs mere